Asarfi Hospital Ltd (ASARFI) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Asarfi Hospital Ltd reported sales of ₹47.53 Cr, operating profit of ₹9.45 Cr (OPM 19.88%) and net profit of ₹4.27 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
ASARFI quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 30.86 32.89 35.1 35.68 44.89 46.1 45.24 47.53 Expenses 24.1 25.93 28.81 28.69 36.02 36 37.51 38.08 Operating Profit 6.76 6.96 6.29 6.99 8.87 10.1 7.73 9.45 OPM 21.91% 21.16% 17.92% 19.59% 19.76% 21.91% 17.09% 19.88% Other Income 1.13 0.89 3.61 1.42 0.76 1.48 0.64 0.57 Interest 0.76 1.18 1.35 1.22 1.07 1.25 0.71 1.17 Depreciation 3.19 3.05 3.25 2.99 2.91 2.88 2.76 3.15 Profit before tax 3.94 3.62 5.3 4.2 5.65 7.45 4.9 5.7 Tax 27.41% 25.69% 32.26% 25.71% 25.66% 27.25% 20.2% 25.26% Net Profit 2.85 2.68 3.59 3.12 4.2 5.42 3.92 4.27 EPS in Rs 1.45 1.36 1.82 1.59 2.13 2.75 1.99 2.17
ASARFI profit & loss, annual (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 TTM Sales 81 116 174 184 Expenses 65 93 138 148 Operating Profit 16 24 35 36 OPM 20% 20% 20% 20% Other Income 2 8 3 3 Interest 3 4 4 4 Depreciation 9 13 12 12 Profit before tax 6 14 22 24 Tax 33% 26% 25% - Net Profit 4 11 17 18 EPS in Rs 2.11 5.38 8.47 9.04 Dividend Payout 0% 0% 0% -
ASARFI balance sheet (₹ Cr) Metric Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 20 20 20 20 Reserves 51 61 69 78 Borrowings 32 49 48 58 Other Liabilities 52 34 36 38 Total Liabilities 154 164 172 193 Fixed Assets 94 102 98 108 CWIP 0 2 4 2 Investments 0 0 0 0 Other Assets 60 60 70 83 Total Assets 154 164 172 193
ASARFI cash flows (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 26 -4 18 Cash from Investing Activity -63 -7 -18 Cash from Financing Activity 36 13 5 Net Cash Flow -1 1 5 Free Cash Flow -20 -15 0 CFO/OP 163% -5% 68%
ASARFI ratios Metric Mar 2024 Mar 2025 Mar 2026 Debtor Days 109 125 114 Inventory Days 32 30 30 Days Payable 447 171 156 Cash Conversion Cycle -305 -16 -12 Working Capital Days 3 50 19 ROCE - 16% 19%